4//SEC Filing
Sucampo Pharmaceuticals, Inc. 4
Accession 0001171843-16-008385
CIK 0001365216operating
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 5:45 PM ET
Size
5.2 KB
Accession
0001171843-16-008385
Insider Transaction Report
Form 4
Lichtlen Peter
Chief Medical Officer
Transactions
- Award
Employee Stock Option (right to buy)
2016-03-02+44,000→ 269,400 totalExercise: $13.80Exp: 2026-03-02→ Class A Common Stock (44,000 underlying)
Footnotes (1)
- [F1]The option vests in 4 equal annual installments beginning on March 2, 2017
Documents
Issuer
Sucampo Pharmaceuticals, Inc.
CIK 0001365216
Entity typeoperating
Related Parties
1- filerCIK 0001365216
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 5:45 PM ET
- Size
- 5.2 KB